| 0 | 💬 0 |
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.
(nature.com)
|
Nature Medicine 2026-05-13 | #metabolism #clinical trial #obesity #glp-1 #weight loss |